The human box C/D snoRNAs U3 and U8 are required for pre-rRNA processing and tumorigenesis
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
// Jean-Louis Langhendries 1 , Emilien Nicolas 1 , Gilles Doumont 3 , Serge Goldman 2, 3 , Denis L.J. Lafontaine 1, 3 1 RNA Molecular Biology, Fonds de la Recherche Scientifique (F.R.S.-FNRS), Université Libre de Bruxelles (ULB), BioPark Campus, Gosselies, Belgium 2 Nuclear Medecine, Erasme Hospital, Université Libre de Bruxelles, Belgium 3 Center for Microscopy and Molecular Imaging (CMMI), BioPark campus, Université Libre de Bruxelles, Belgium Correspondence to: Denis L.J. Lafontaine, email: denis.lafontaine@ulb.ac.be Keywords: snoRNA, nucleolus, ribosome, tumorigenesis, cancer Received: April 11, 2016 Accepted: June 30, 2016 Published: August 09, 2016 ABSTRACT Small nucleolar RNAs (snoRNAs) are emerging as a novel class of proto-oncogenes and tumor suppressors; their involvement in tumorigenesis remains unclear. The box C/D snoRNAs U3 and U8 are upregulated in breast cancers. Here we characterize the function of human U3 and U8 in ribosome biogenesis, nucleolar structure, and tumorigenesis. We show in breast (MCF-7) and lung (H1944) cancer cells that U3 and U8 are required for pre-rRNA processing reactions leading, respectively, to synthesis of the small and large ribosomal subunits. U3 or U8 depletion triggers a remarkably potent p53-dependent anti-tumor stress response involving the ribosomal proteins uL5 (RPL11) and uL18 (RPL5). Interestingly, the nucleolar structure is more sensitive to perturbations in lung cancer than in breast cancer cells. We reveal in a mouse xenograft model that the tumorigenic potential of cancer cells is reduced in the case of U3 suppression and totally abolished upon U8 depletion. Tumors derived from U3-knockdown cells displayed markedly lower metabolic volume and activity than tumors derived from aggressive control cancer cells. Unexpectedly, metabolic tracer uptake by U3-suppressed tumors appeared more heterogeneous, indicating distinctive tumor growth properties that may reflect non-conventional regulatory functions of U3 (or fragments derived from it) in mRNA metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, we observed effects on the 3′-end maturation of 5.8S rRNA, a well-established RNA exosome substrate and the substrate on which the RNA exosome was originally identified [37], as well as accumulation of 34S pre-rRNA linked to ADAR interaction with the 5′–3′ exonuclease XRN2 [52, 71, 91].”
From ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability (2026) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803 · cited 1×
“Use of HCT116 cells expressing p53 or not in an otherwise isogenic background [44], allowed us to further conclude that the involvement of U3 and U8 in processing does not require the presence of p53 (data not shown).”
Background
Cited by
Small Nucleolar RNAs: Insight Into Their Function in Cancer
Liang, J., Wen, J., Huang, Z., Chen, X.-P., Zhang, B.-X., & Chu, L. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00587 · Cited by 269
Lessard, F., Igelmann, S., Trahan, C., Huot, G., Saint-Germain, E., Mignacca, L., Del Toro, N., Lopes-Paciencia, S., Le Calvé, B., Montero, M., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0127-y · Cited by 174
“…more unstable ribosome biogenesis factors RSL1D1 (ribosomal L1 domain containing 1) 24 , nucleostemin (NS or GNL3) 24,25 , DDX21 (DExD-Box helicase 21) 25 and EBP2 (EBNA1 binding protein 2; also known as EBNA1BP2) 25 were downregulated at the protein level in Ras -senescent, PML-senescent and old…”
BackgroundResultBox C/D small nucleolar RNA genes and the Prader‐Willi syndrome: a complex interplay
Cavaillé, J. (2017) · WIREs RNA · doi:10.1002/wrna.1417 · Cited by 86
snoRNAs offer novel insight and promising perspectives for lung Cancer understanding and management
Mourksi, N.-E.-H., Morin, C., Fenouil, T., Diaz, J.-J., & Marcel, V. (2020) · Cells · doi:10.3390/cells9030541 · Cited by 62
Small nucleolar RNA and its potential role in breast cancer – A comprehensive review
Dsouza, V. L., Adiga, D., Sriharikrishnaa, S., Suresh, P. S., Chatterjee, A., & Kabekkodu, S. P. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188501 · Cited by 48
Breast Cancer and the Other Non-Coding RNAs
Dvorská, D., Braný, D., Ňachajová, M., Halašová, E., & Danková, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063280 · Cited by 38
ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability
Vukić, D., Du, Q., Cherian, A., Amoruso, D., Brožinová, K., Wacheul, L., Lacovich, V., Zorbas, C., Yadav, L., Sedmík, J., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag381
Self-citation
Metadata
- Authors
- Langhendries, J.-L., Nicolas, E., Doumont, G., Goldman, S., & Lafontaine, D. L. J.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-08-09
- Volume
- 7
- Issue
- 37
- Pages
- 59519-59534
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2509320946
- Cited by
- 97
- References
- 1
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.